BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 224 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q2 2021. The put-call ratio across all filers is 1.19 and the average weighting 0.8%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $46,000 | -63.8% | 306 | -65.0% | 0.00% | – |
| Q2 2022 | $127,000 | +81.4% | 874 | +49.1% | 0.00% | – |
| Q1 2022 | $70,000 | +2.9% | 586 | +19.1% | 0.00% | – |
| Q4 2021 | $68,000 | +580.0% | 492 | +593.0% | 0.00% | – |
| Q3 2021 | $10,000 | +900.0% | 71 | +688.9% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 9 | -30.8% | 0.00% | – |
| Q1 2021 | $1,000 | -96.0% | 13 | -95.4% | 0.00% | – |
| Q4 2020 | $25,000 | +2400.0% | 284 | +2740.0% | 0.00% | – |
| Q4 2019 | $1,000 | – | 10 | 0.0% | 0.00% | – |
| Q3 2019 | $0 | -100.0% | 10 | -96.5% | 0.00% | – |
| Q2 2019 | $12,000 | +300.0% | 288 | +433.3% | 0.00% | – |
| Q1 2019 | $3,000 | – | 54 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 450,422 | $6,251,857 | 14.11% |
| Liontrust Investment Partners LLP | 134,659 | $7,478,961 | 0.13% |
| Birchview Capital, LP | 7,365 | $102 | 0.07% |
| FNY Investment Advisers, LLC | 250 | $3 | 0.00% |
| FNY Investment Advisers, LLC | 18 | $0 | 0.00% |
| FNY Investment Advisers, LLC | 56 | $0 | 0.00% |
| McElhenny Sheffield Capital Management, LLC | 31 | $430 | 0.00% |
| Blue Trust, Inc. | 65 | $10 | 0.00% |
| IFP Advisors, Inc | 1 | $1 | 0.00% |